1. Home
  2. TUYA vs DVAX Comparison

TUYA vs DVAX Comparison

Compare TUYA & DVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tuya Inc. each representing one

TUYA

Tuya Inc. each representing one

HOLD

Current Price

$2.20

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Dynavax Technologies Corporation

DVAX

Dynavax Technologies Corporation

N/A

Current Price

$15.36

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TUYA
DVAX
Founded
2014
1996
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2021
2004

Fundamental Metrics

Financial Performance
Metric
TUYA
DVAX
Price
$2.20
$15.36
Analyst Decision
Strong Buy
Hold
Analyst Count
1
5
Target Price
$3.49
$26.50
AVG Volume (30 Days)
881.9K
3.0M
Earning Date
11-24-2025
11-05-2025
Dividend Yield
4.89%
N/A
EPS Growth
N/A
N/A
EPS
0.08
N/A
Revenue
$319,363,000.00
$330,514,000.00
Revenue This Year
$8.84
$24.63
Revenue Next Year
$12.17
$15.85
P/E Ratio
$28.75
N/A
Revenue Growth
13.66
26.73
52 Week Low
$1.57
$9.20
52 Week High
$4.63
$15.49

Technical Indicators

Market Signals
Indicator
TUYA
DVAX
Relative Strength Index (RSI) 45.75 89.09
Support Level $2.18 $10.78
Resistance Level $2.31 $15.49
Average True Range (ATR) 0.06 0.22
MACD -0.00 0.44
Stochastic Oscillator 25.81 97.84

Price Performance

Historical Comparison
TUYA
DVAX

About TUYA Tuya Inc. each representing one

Tuya Inc is an AI cloud platform service provider dedicated to bringing AI into everyday life. The group leverages its TuyaOpen open-source framework and universal AI Agent engines, including the AI Agent development platform, to integrate multimodal AI capabilities and reduce barriers to AI development. It drives the adoption of AI-powered lifestyles and speeds up the integration of AI with the physical world. It offers innovative physical AI solutions for smart devices, commercial use, and industry developers using cloud computing and spatial intelligence. It also provides a complete, open, and neutral global AIoT ecosystem. It builds a developer community that collaborates to create smart solutions grounded in sustainability, security, efficiency, agility, and openness.

About DVAX Dynavax Technologies Corporation

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Share on Social Networks: